Geode Capital Management’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.9M | Buy |
954,560
+152,560
| +19% | +$2.06M | ﹤0.01% | 2186 |
|
|
2025
Q1 | $12.7M | Buy |
802,000
+181,967
| +29% | +$2.89M | ﹤0.01% | 2143 |
|
|
2024
Q4 | $7.63M | Sell |
620,033
-820
| -0.1% | -$10.1K | ﹤0.01% | 2529 |
|
|
2024
Q3 | $7.52M | Buy |
620,853
+38,527
| +7% | +$467K | ﹤0.01% | 2533 |
|
|
2024
Q2 | $6.81M | Buy |
582,326
+199,562
| +52% | +$2.34M | ﹤0.01% | 2563 |
|
|
2024
Q1 | $4.94M | Buy |
382,764
+6,442
| +2% | +$83.2K | ﹤0.01% | 2714 |
|
|
2023
Q4 | $3.24M | Buy |
376,322
+76,359
| +25% | +$657K | ﹤0.01% | 2912 |
|
|
2023
Q3 | $2.85M | Buy |
299,963
+13,304
| +5% | +$127K | ﹤0.01% | 2927 |
|
|
2023
Q2 | $4.89M | Buy |
286,659
+3,006
| +1% | +$51.3K | ﹤0.01% | 2686 |
|
|
2023
Q1 | $4.44M | Buy |
+283,653
| New | +$4.44M | ﹤0.01% | 2684 |
|